Evidence map›Paper›PMID 33215900›Full record

ArticleTransplantation2020

Simultaneous Liver Kidney Transplant in Elderly Patients With Chronic Kidney Disease: Is There an Appropriate Upper Age Cutoff?

David S Goldberg, Rodrigo M Vianna, Eric Fleming Martin, Paul Martin, Leopoldo Ramon Arosemena Benitez, Christopher Blackburn O'Brien, Kalyan R Bhamidimarri

Open access · greenAbstract readComparative Study
In one paragraph

Article in Transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Simultaneous Liver-Kidney Transplantation versus Liver Transplantation in End-Stage Liver Disease Patients with Kidney Dysfunction.European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David S GoldbergDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
Rodrigo M ViannaMiami Transplant Institute, Jackson Health System, Miami, FL.
Eric Fleming MartinDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
Paul MartinDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
Leopoldo Ramon Arosemena BenitezDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
Christopher Blackburn O'BrienDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
Kalyan R BhamidimarriDivision of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
University of Miami · USJackson Health System · US

Funding

Using ethics, epidemiology and high-quality data to optimize the allocation of livers for transplantationR01DK120561 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GOLDBERG, DAVID SETH · 2019 to 2023
$2.7M
NIDDK NIH HHS R01 DK120561
6 · The paper itself

Abstract

backgroundThe aging of liver transplant (LT) recipients, the weighting of the model for end-stage liver disease score, and the increased prevalence of nonalcoholic steatohepatitis has led to an increased number of older LT recipients with pre-LT chronic kidney disease (CKD). There are limited data on the impact of increased recipient age on post-simultaneous liver-kidney (SLK) transplant outcomes among patients with CKD, leading some centers to employ subjective age cutoffs for potential SLK recipients.

methodsWe evaluated United Network for Organ Sharing data of adult SLK recipients from February 27, 2002, to December 31, 2018, restricted to recipients with ≥90 days of waiting time and CKD (estimated glomerular filtration rate persistently <60 mL/min/1.73 m2 for ≥90 d using the modification of diet in renal disease-4 equation). We fit mixed-effects Cox regression models (center as random effect) to evaluate the association of recipient age and patient survival.

resultsAmong 3146 SLK recipients with CKD, nearly two-thirds were 50-64 years of age, while 465 (14.8%) and 93 (3.0%) were 65-69 years and ≥70 years, respectively. Compared with nondiabetic SLK recipients aged 50-59 years, SLK recipients ≥70 years of age without diabetes (hazard ratio, 1.97; 95% CI, 1.20-3.23; P = 0.007) and with diabetes (hazard ratio, 1.90; 95% CI, 1.16-3.09; P = 0.01) had higher mortality compared with the reference group. In absolute terms, SLK recipients ≥70 years of age had 25% lower patient survival at 5 years compared to recipients aged 40-49 years.

conclusionsAlthough careful selection is required of any SLK recipient, especially those with increased comorbidities, there are no objective data to justify a specific age cutoff <70 years among potential SLK recipients with CKD.

Indexed as

Kidney TransplantationLiver TransplantationAgedAge FactorsClinical Decision-MakingComorbidityFemaleHumansLiver FailureMaleMiddle AgedPatient SelectionRenal Insufficiency, ChronicRisk AssessmentRisk FactorsTreatment Outcome

Identifiers

PMID33215900
PMCPMC8721602
OpenAlexW3005528075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.